Who invested in Cortexyme?
Cortexyme's investors include Sequoia Capital, Pfizer, Dolby Family Ventures, Vulcan and Takeda Digital Ventures, and 7 more on record.

United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$77Mraised across 3 rounds since 2014, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEsSEC filing: $84M sold, first sale May 2018
No investor was named in the report.
From a historical funding record
From the SEC filings it signed: 2 on the team.
On the board, as filediDavid LamondIlan ZipkinMargi McLoughlinRoger QuyStephen Dominy
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Cortexyme's investors include Sequoia Capital, Pfizer, Dolby Family Ventures, Vulcan and Takeda Digital Ventures, and 7 more on record.
Cortexyme has raised $77M across 3 rounds since 2014. One round did not disclose an amount, so the total is a floor.
Cortexyme's most recent round was a Series B of $76M in May 2018.
Its most recent round, $76M in May 2018, is also its largest on record.
Cortexyme's first round on record, in Jun 2014, was backed by Breakout Labs.
Cortexyme's latest named round is a Series B, in May 2018.
Cortexyme is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.